Australia markets closed

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4210+0.0100 (+2.43%)
At close: 04:00PM EDT
0.4153 -0.01 (-1.35%)
After hours: 05:34PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
Operating expenses
Research development
18,431
21,449
14,363
6,946
Selling general and administrative
11,530
11,870
12,202
10,123
Total operating expenses
29,961
33,318
26,565
17,069
Operating income or loss
-29,961
-33,318
-26,565
-17,069
Interest expense
10.696
24.047
32.33
7.686
Total other income/expenses net
-739.692
-582.62
1,176
-307.528
Income before tax
-30,417
-33,776
-25,409
-17,385
Income from continuing operations
-30,417
-33,776
-25,409
-17,385
Net income
-30,417
-33,776
-25,409
-17,385
Net income available to common shareholders
-30,417
-33,776
-25,409
-17,385
Basic EPS
-18.60
-20.80
-18.60
-17.80
Diluted EPS
-18.60
-20.80
-18.60
-17.80
Basic average shares
1,628
1,624
1,365
981.014
Diluted average shares
1,628
1,624
1,365
981.014